CH Biotech R&D Co., Ltd. (TPE:6534)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
95.10
-0.10 (-0.11%)
Aug 15, 2025, 1:30 PM CST

CH Biotech R&D Market Cap

CH Biotech R&D has a market cap or net worth of 9.78 billion as of August 15, 2025. Its market cap has increased by 17.41% in one year.

Market Cap
9.78B
Enterprise Value
10.04B
Revenue
1.68B
Ranking
n/a
PE Ratio
26.97
Stock Price
95.10

Market Cap Chart

Since July 2, 2015, CH Biotech R&D's market cap has increased from 7.47B to 9.78B, an increase of 30.87%. That is a compound annual growth rate of 2.69%.

History

DateMarket Cap% Change
Aug 15, 20259.78B17.70%
Dec 31, 20248.31B0.37%
Dec 29, 20238.28B13.05%
Dec 30, 20227.32B42.15%
Dec 30, 20215.15B20.79%
Dec 31, 20204.26B-25.79%
Dec 31, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Nan Ya Plastics 340.63B
China Steel 312.46B
Formosa Plastics 253.04B
TCC Group Holdings 178.49B
Formosa Chemicals & Fibre 172.55B
Asia Cement 139.73B
Walsin Lihwa 101.70B
Taiwan Glass Ind. 98.87B
Market Cap Rankings